MAPT and epilepsy: Investigations into novel pharmacological interventions targeting tau hyperphosphorylation in epilepsy have therefore concentrated on inhibiting and enhancing related phosphorylation and dephosphorylation mechanisms, respectively (Zheng et al., 2014; Ali et al., 2019).